Clínic Barcelona

Hospital Clínic-IDIBAPS and the CIBER have signed an agreement with Eiken Chemical to assess the efficacy of a new fecal test for screening for colorectal cancer

The Japanese company, leader in screening for colorectal cancer worldwide, will fund the first phase of a multicenter clinical trial led by Antoni Castells and Meritxell Gironella, which will analyze the efficacy and profitability of the new test developed by the researchers.

Antoni Castells (en el centro) y Meritxell Gironella (segunda por la derecha) recibieron a representantes de la empresa Eiken Chemical en su reciente visita al Clínic-IDIBAPS.

Related contents
Keep reading about:

Related news